The body loses functional reserve starting in the thirties
À medida que o Brasil envelhece em ritmo acelerado, uma pesquisa do Hospital Sírio-Libanês revela que mais de 70% das internações de idosos envolvem alertas sobre medicamentos potencialmente inapropriados — um sinal de que o sistema de saúde ainda não aprendeu a cuidar do corpo que envelhece. Fármacos comuns como omeprazol e ciprofloxacino, tolerados por adultos mais jovens, podem provocar declínio cognitivo e pneumonia em pacientes com mais de sessenta anos, cujas reservas fisiológicas já não absorvem os mesmos riscos. A tecnologia para corrigir esse problema existe; o que falta é a vontade coletiva de aplicá-la.
- Mais de 71% das internações de idosos analisadas no Sírio-Libanês acionaram ao menos um alerta de medicamento de risco — uma proporção que revela não uma exceção, mas uma norma perigosa.
- Omeprazol, vendido livremente em farmácias, e ciprofloxacino, antibiótico de uso comum, podem causar confusão mental aguda e pneumonia em pacientes idosos, efeitos que muitos médicos sem formação geriátrica ainda subestimam.
- A inércia clínica agrava o problema: médicos frequentemente mantêm prescrições de alto risco simplesmente porque o paciente 'já tomava' aquele medicamento, sem reavaliar o impacto sobre um organismo que mudou com a idade.
- Um sistema de inteligência artificial já opera no Sírio-Libanês, cruzando dados do paciente com alertas de segurança em tempo real antes que a prescrição seja finalizada — e funciona.
- O verdadeiro gargalo está fora dos departamentos de geriatria: clínicos gerais, cardiologistas e gastroenterologistas tratam a maioria dos idosos brasileiros sem o repertório necessário para prescrever com segurança para essa faixa etária.
O Brasil está envelhecendo mais rápido do que seu sistema de saúde consegue acompanhar. Em doze anos, a população acima de sessenta e cinco anos cresceu quase 57,5%, e as projeções indicam que esse grupo chegará a 75,3 milhões de pessoas até 2070. Nesse cenário, uma pesquisa do Centro de Medicina Avançada do Hospital Sírio-Libanês analisou cerca de 15 mil internações de pacientes com sessenta anos ou mais e encontrou um dado alarmante: em 71,8% dos casos, houve ao menos um alerta para uso de medicamento potencialmente inapropriado para idosos.
O corpo envelhecido funciona de forma diferente. A partir dos trinta anos, o organismo começa a perder a chamada reserva funcional — a capacidade de absorver estresse e se recuperar sem danos duradouros. Isso significa que drogas bem toleradas por adultos mais jovens podem se acumular a níveis tóxicos em um paciente de setenta anos, especialmente quando ele já toma múltiplos medicamentos para doenças crônicas simultâneas.
Dois medicamentos se destacaram no estudo. O omeprazol, redutor de acidez estomacal vendido sem receita em todo o Brasil, interfere na absorção de vitamina B12, está associado ao declínio cognitivo e pode favorecer pneumonias por aspiração em idosos hospitalizados. O ciprofloxacino, antibiótico potente, pode desencadear confusão mental aguda — desorientação, agitação, alteração do sono — muitas vezes nas primeiras vinte e quatro horas de uso em pacientes acima de sessenta e cinco anos.
Por que essas prescrições persistem? O estudo identificou que médicos sem formação geriátrica frequentemente subestimam os riscos e mantêm medicamentos de alto risco por inércia: o paciente já tomava, então a receita continua. Essa lógica ignora que o organismo do idoso não é o mesmo de anos atrás.
A resposta tecnológica já existe. No próprio Sírio-Libanês, um sistema de inteligência artificial monitora a segurança das prescrições em tempo real, cruzando idade, condição clínica e interações medicamentosas antes que o médico finalize o pedido. O sistema funciona. O desafio agora é expandir essa proteção para além dos grandes centros especializados — levando o conhecimento geriátrico até os clínicos gerais, cardiologistas e especialistas que, na prática, atendem a maioria dos idosos brasileiros.
Brazil is aging faster than its health system is prepared to handle. In the past twelve years, the population over sixty-five has grown by nearly 57.5 percent. By 2070, demographers expect that age group to reach 75.3 million people—nearly a third of the country. This demographic shift has exposed a dangerous gap in how hospitals prescribe medication to their oldest patients.
A study conducted by the Advanced Medicine Center at Hospital Sírio-Libanês examined roughly 15,000 hospitalizations of people aged sixty and older. The researchers used a clinical decision-support system embedded in the hospital's electronic health records to flag potentially inappropriate medications—drugs that carry heightened risks for elderly patients. The findings were stark: in 71.8 percent of those admissions, at least one alert appeared for medication use that posed special danger to someone in their sixties or beyond.
The elderly body works differently than a younger one. After age thirty, the human body begins a slow loss of what doctors call functional reserve—the physiological cushion that allows an organism to absorb stress and recover without lasting damage. This decline means that drugs tolerated easily by a forty-year-old can accumulate to toxic levels in a seventy-year-old. Older patients also tend to manage multiple chronic conditions simultaneously, requiring more medications, which multiplies the risk of harmful interactions. They are simply more vulnerable to adverse events.
Two medications emerged as particularly troubling in the study. Omeprazole, a stomach acid reducer sold over the counter in pharmacies across Brazil, was among the most frequently flagged. The drug is convenient and effective for heartburn, but in elderly patients it interferes with vitamin B12 absorption and has been linked to cognitive decline. In hospitalized seniors with reflux disease, omeprazole's reduction of stomach acid can allow bacteria to proliferate, raising the risk of aspiration pneumonia. Many older Brazilians take it without a doctor's recommendation, unaware of these risks. Ciprofloxacin, a powerful antibiotic prescribed for serious bacterial infections, can trigger acute mental confusion in elderly patients—disorientation, agitation, altered sleep, sometimes within the first twenty-four hours of use. These are not rare side effects in people over sixty-five or those with existing cognitive problems.
Why do these medications persist in prescriptions for elderly patients? The study found that many clinicians, particularly those without geriatric training, underestimate the risks. When questioned about continuing high-risk drugs, physicians often justified the choice by noting that the patient was already taking the medication chronically. Inertia and unfamiliarity with age-specific pharmacology create a dangerous default: the prescription continues because it always has.
The solution is already available. At Hospital Sírio-Libanês, an artificial intelligence system now monitors medication safety in real time. The tool cross-references patient age, clinical condition, and drug interactions against a database of safety information, generating alerts directly in the physician's electronic record before a prescription is finalized. The system flags not only potentially inappropriate medications but also dangerous drug combinations. It works. The question now is whether Brazil's broader health system will adopt and expand these safeguards.
The challenge extends beyond geriatric specialists. Most elderly patients are treated by general practitioners, cardiologists, gastroenterologists, and other non-geriatric physicians who may not routinely consider how a drug affects a sixty-eight-year-old differently than a forty-five-year-old. As Brazil's population ages, that knowledge gap becomes a public health crisis. The technology to close it exists. What remains is the will to implement it across the system.
Notable Quotes
Many clinicians, particularly those without geriatric training, underestimate the risks and justify continuing high-risk drugs by noting the patient was already taking them chronically— Hospital Sírio-Libanês study findings
The Hearth Conversation Another angle on the story
Why does a medication that works fine for a younger person become dangerous for an older one?
The body loses what we call functional reserve starting in the thirties. It's like the difference between a new car that can absorb a pothole and an old one that feels every bump. By sixty-five, the liver breaks down drugs more slowly, the kidneys filter less efficiently, and the brain is more sensitive to chemical changes. The same dose that's safe at forty-five can accumulate to toxic levels at seventy-five.
The study found omeprazole in over-the-counter stomach medication was a major problem. Why is that particular drug so risky?
It's everywhere, which is part of the problem. People buy it without a prescription. But in elderly patients, it blocks vitamin B12 absorption, which affects cognition. And if an older person is hospitalized and has reflux, the drug lets bacteria grow in the stomach, which can lead to aspiration pneumonia. The benefit for heartburn gets outweighed by these hidden risks.
The study mentions that doctors often keep prescribing these drugs because patients are already taking them. That sounds like inertia.
Exactly. There's a kind of momentum in prescribing. A patient comes in on omeprazole, and unless someone specifically reviews whether it's still appropriate, it stays. Many physicians outside geriatrics don't have the training to recognize which drugs are problematic for older bodies. It's not malice—it's a gap in knowledge.
What does the AI system actually do?
It watches in real time. When a doctor enters a prescription, the system checks the patient's age and conditions against a database of drug safety information. If there's a risk—either because the drug itself is inappropriate for that age or because it interacts badly with something else the patient takes—an alert pops up immediately. It's like a second opinion built into the workflow.
Does that mean the doctor has to stop prescribing the drug?
Not necessarily. The alert is a flag, not a block. But it forces a moment of deliberation. The doctor has to consciously decide whether the benefit outweighs the risk for that specific patient. That pause is often enough to change the outcome.
If this technology works, why isn't it everywhere?
Cost, implementation, and the fact that many hospitals and clinics haven't yet grasped the scale of the problem. Brazil's population is aging rapidly, but the health system hasn't fully adapted. The technology exists. The barrier now is institutional will and resources.